Bioverativ Inc.: key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2017)
- $1.2B
- Net Income/Loss (FY2017)
- $355.6M
- Total Assets (FY2017)
- $1.6B
- Total Equity (FY2017)
- $897.6M
- Cash Flows from Operating Activities (FY2017)
- $590.7M
Source: Bioverativ Inc. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
